Search research articles
Contact Us
Filters
Showing results (381-390 of 430) with videos related to
Page
of 43
Sort By:
The Lancet. Respiratory Medicine
|
April 17, 2025
Efficacy, safety, and immunogenicity of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial
Michael G Ison, Alberto Papi, Eugene Athan, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 1, 2023
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí, Bartolome R Celli, Gerard J Criner, et al.
The European Respiratory Journal
|
March 1, 2023
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí, Bartolome R Celli, Gerard J Criner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 22, 2024
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Michael G Ison, Alberto Papi, Eugene Athan, et al.
Respirology (Carlton, Vic.)
|
March 1, 2023
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí, Bartolome R Celli, Gerard J Criner, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 2, 2020
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6
Teresa C Williams, David J Jackson, Steven Maltby, et al.
The New England Journal of Medicine
|
June 5, 2023
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
The Lancet. Respiratory Medicine
|
October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study
Stanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy
|
November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort
Pauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
The New England Journal of Medicine
|
May 22, 2019
Benralizumab for the Prevention of COPD Exacerbations
Gerard J Criner, Bartolome R Celli, Christopher E Brightling, et al.
Page
of 43
Search research articles
Search
Showing results (381-390 of 430) with videos related to
Sort By:
Page
of 43
The Lancet. Respiratory Medicine
|
April 17, 2025
Efficacy, safety, and immunogenicity of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial
Michael G Ison, Alberto Papi, Eugene Athan, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 1, 2023
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí, Bartolome R Celli, Gerard J Criner, et al.
The European Respiratory Journal
|
March 1, 2023
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí, Bartolome R Celli, Gerard J Criner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 22, 2024
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Michael G Ison, Alberto Papi, Eugene Athan, et al.
Respirology (Carlton, Vic.)
|
March 1, 2023
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí, Bartolome R Celli, Gerard J Criner, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 2, 2020
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6
Teresa C Williams, David J Jackson, Steven Maltby, et al.
The New England Journal of Medicine
|
June 5, 2023
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
The Lancet. Respiratory Medicine
|
October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study
Stanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy
|
November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort
Pauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
The New England Journal of Medicine
|
May 22, 2019
Benralizumab for the Prevention of COPD Exacerbations
Gerard J Criner, Bartolome R Celli, Christopher E Brightling, et al.
Page
of 43